Every open market buy and sale of Prelude Therapeutics Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are buying over the last 12 months: $25M bought and $0 sold.
Buying and selling by month
open market, last 12 monthsGet an alert when PRLD insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an PRLD officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
PRLD cluster buys
All PRLD cluster buys →- 2 insiders bought $25MTrades Apr 21, 2026 to Apr 21, 2026 · public Apr 23, 2026
A cluster buy is two or more insiders buying on the open market within 30 days of each other.
Every PRLD insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Orbimed Advisors LLCDirector | Buy | 2,815,315 | $4.44 | $12.5M | 1,126,126 | Apr 23Form 4 |
| Apr 21, 2026 | David P BonitaDirector | Buy | 2,815,315 | $4.44 | $12.5M | 1,126,126 | Apr 23Form 4 |
| Mar 25, 2025 | Krishna VaddiCEO | Buy | 675,000 | $0.69 | $466K | 1,999,296 | Mar 27Form 4 |
| Mar 25, 2025 | Andrew CombsChief Chemistry Officer | Buy | 100,000 | $0.69 | $69K | 480,123 | Mar 27Form 4 |
| Mar 21, 2025 | Krishna VaddiCEO | Buy | 20,416 | $0.73 | $15K | 1,324,296 | Mar 24Form 4 |
| Mar 17, 2025 | Krishna VaddiCEO | Buy | 39,105 | $0.75 | $29K | 1,303,880 | Mar 18Form 4 |
| Mar 13, 2025 | Krishna VaddiCEO | Buy | 97,500 | $0.72 | $70K | 1,264,775 | Mar 14Form 4 |
| Dec 31, 2024 | Krishna VaddiCEO | Buy | 5,000 | $1.21 | $6K | 142,553 | Jan 3Form 4 |
| Dec 30, 2024 | Krishna VaddiCEO | Buy | 10,000 | $1.20 | $12K | 137,553 | Jan 2Form 4 |
| Dec 23, 2024 | Andrew CombsChief Chemistry Officer | Buy | 63,075 | $1.36 | $86K | 377,623 | Dec 26Form 4 |
| Dec 19, 2024 | Krishna VaddiCEO | Buy | 106,888 | $0.93 | $99K | 127,553 | Dec 20Form 4 |
| Dec 19, 2024 | Bryant David LimCLO, Interim CFO, Corp Sec. | Buy | 25,000 | $0.91 | $23K | 27,400 | Dec 20Form 4 |
PRLD insider trading FAQ
Are PRLD insiders buying or selling?
Insiders are buying over the last 12 months. 2 insiders bought $25M of PRLD on the open market in 2 trades, and 0 sold $0 in 0 trades.
When did an PRLD insider last buy shares?
Orbimed Advisors LLC (Director) bought 2,815,315 shares for $12.5M on Apr 21, 2026, reported on Apr 23, 2026.
When did an PRLD insider last sell shares?
There has been no open market insider sale of PRLD in the last two years.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
